Results 71 to 80 of about 795,232 (125)

Anticancer effect of chrysin on canine mammary gland tumor cells via cell cycle arrest and apoptosis

open access: yesJournal of Animal Reproduction and Biotechnology
Background: Canine mammary tumors are one of the most common tumors in female dogs, and the development of effective therapeutic agents is a critical clinical challenge.
Hyeon Woo Sim   +6 more
doaj   +1 more source

Analysis of EGFR and HER-2 expressions in ductal carcinomas in situ in canine mammary glands

open access: yesArquivo Brasileiro de Medicina Veterinária e Zootecnia, 2014
Biomolecular evidence has shown that ductal carcinoma in situ (DCIS) may develop into invasive carcinoma of the canine mammary gland, and mutations in proto-oncogenes HER2 and EGFR; two members of the family of epidermal growth factor receptors, may be ...
I.L.D. Silva   +4 more
doaj   +1 more source

Supplemental Material, DS2_VET_10.1177_0300985818813653 - CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors

open access: yes, 2019
Supplemental Material, DS2_VET_10.1177_0300985818813653 for CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors by Bernadette Rogez, Quentin Pascal, Audrey Bobillier, François Machuron, Chann Lagadec, Dominique Tierny, Xuefen Le
Valérie Chopin (6094721)   +7 more
core   +1 more source

Altered oxidative stress and carbohydrate metabolism in canine mammary tumors [PDF]

open access: yes, 2016
Aim: Mammary tumors are the most prevalent type of neoplasms in canines. Even though cancer induced metabolic alterations are well established, the clinical data describing the metabolic profiles of animal tumors is not available.
K. Jayasri, K. Padmaja, M. Saibaba
core   +2 more sources

Epidemiological investigation and surgical treatment of canine mammary tumors in Dalian, China, from 2019 to 2023.

open access: yesPLoS ONE
Objective of this study is to investigate the epidemiological characteristics, clinical features, and treatment outcomes of canine mammary tumors in Dalian, providing insights into prevention and management strategies.
Zheng Jing, Jiawang Feng, Hongyan Jin
doaj   +1 more source

A role of ghrelin in canine mammary carcinoma cells proliferation, apoptosis and migration

open access: yesBMC Veterinary Research, 2012
Background Ghrelin is a natural ligand of the growth hormone secretagogue receptor (GHS-R). They are often co-expressed in multiple human tumors and related cancer cell lines what can indicate that the ghrelin/GHS-R axis may have an important role in ...
Majchrzak Kinga   +6 more
doaj   +1 more source

Gene Ontology and Pathway Analysis Data for Oncogenic microRNAs in Canine Mammary Tumors

open access: yes
This dataset supports the research entitled "Evaluation of Multiple Serum miRNAs as Biomarker Candidates for Tumor Progression in Canine Mammary Gland Tumors." The study investigates the expression and clinical relevance of five serum microRNAs—cfa-miR ...
Benevenuto, Luíz
core   +1 more source

A comparative review of mixed mammary tumors in mammals

open access: yes, 2019
Mixed tumors are characterized by the histological identification of two or more cell types. Commonly, a mixture of epithelial and myoepithelial cells is included in abundant stroma, which can consist of myxoid, chondroid or bony matrices.
Saad, Eman S.   +6 more
core   +1 more source

Supplemental Material, DS1_VET_10.1177_0300985818813653 - CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors

open access: yes, 2019
Supplemental Material, DS1_VET_10.1177_0300985818813653 for CD44 and CD24 Expression and Prognostic Significance in Canine Mammary Tumors by Bernadette Rogez, Quentin Pascal, Audrey Bobillier, François Machuron, Chann Lagadec, Dominique Tierny, Xuefen Le
Valérie Chopin (6094721)   +7 more
core   +1 more source

EXPRESSION OF E-CADHERINE IN CANINE MAMMARY TUMORS [PDF]

open access: yes
Reduction of expression of E-cadherin in canine mammary tumors has been correlated with invasive behavior, lymph node metastases and shorter survival period after tumor removal.
Karabolovski, Nikola   +8 more
core  

Home - About - Disclaimer - Privacy